Home › Sun Pharma denies its units role in 24 surge in Ranbaxy shares
 

Keywords :   


Sun Pharma denies its units role in 24 surge in Ranbaxy shares

2014-05-05 22:28:29| Chemicals - Topix.net

Sun Pharmaceutical Industries Ltd, which is set to buy rival drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, said its unit Silverstreet Developers LLP had no role to play in the run-up in Ranbaxy shares ahead of the deal announcement in April.

Tags: role sun units shares

Category:Chemicals

Latest from this category

All news
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
20.09New Acrylic Resin for Architectural Coatings Without Fluorosurfactants from EPS
20.09¦nie¿ka Publishes Results for 1H 2024
20.09Sheboygan Paint Company Appoints Fallon Phillip HR Director
20.09RadTech Europe (RTE) Sets Call for Papers
19.09Lubrizol Enhances Dispersant Production Capacity in North America
19.09PPG Announces Two-year Partnership with Foundation for Environmental Education
Chemicals »
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
More »